This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Ototoxic hearing loss, drug-induced
H8_HL_OTOTOX_ADVERSE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
5 |
4. Check minimum number of eventsNone |
5 |
5. Include endpointsNone |
5 |
6. Filter based on genotype QC (FinnGen only) |
5 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF5
- Parent code in ICD-10
- H91
- Name in latin
- Hypacusis ototoxica
Similar endpoints
↥List of similar endpoints to
Ototoxic hearing loss, drug-induced
based on the number of shared cases.
Similar with more cases:
- Ototoxic hearing loss
- Other hearing loss
- Other disorders of ear
- Diseases of the ear and mastoid process
- Any reimbursement code in KELA
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (not available in FinRegistry).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5 | - | - |
| Unadjusted period prevalence (%) | 0.00 | - | - |
| Median age at first event (years) | 49.49 | - | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
0
18
0.00
0.80
0.0
4.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
0
16
0.00
0.51
0.0
2.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
5
35
+∞
0.51
20.2
23.0
%
14.1
13.8
—
5
35
(3044640) Blood type and Crossmatch panel - Blood
0
11
0.00
0.24
0.0
4.6
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
0
9
0.00
0.24
0.0
1.8
—
26.6
—
0
9
(40761511) CBC panel - Blood by Automated count
5
41
+∞
0.24
20.8
19.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
0
9
0.00
0.24
0.0
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
5
41
+∞
0.24
22.6
16.3
mg/l
27.8
24.6
—
5
34
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
5
43
+∞
0.00
10.6
11.5
u/l
28.0
28.9
—
5
43
(3020564) Creatinine [Moles/volume] in Serum or Plasma
5
43
+∞
0.00
22.2
18.9
umol/l
86.0
83.4
—
5
43
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
0
8
0.00
0.00
0.0
4.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (not available in FinRegistry).
Relationships between endpoints
↥Index endpoint: H8_HL_OTOTOX_ADVERSE – Ototoxic hearing loss, drug-induced
GWS hits: -
This endpoint is excluded (not available in FinRegistry).